Nutritional issues in treating phenylketonuria

被引:50
作者
Feillet, Francois [1 ]
Agostoni, Carlo [2 ]
机构
[1] Hop Enfants, CHU Brabois, INSERM,U954, Ctr Reference Malad Hereditaires Metab Nancy, F-54500 Vandoeuvre Les Nancy, France
[2] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dept Maternal & Pediat Sci, I-20122 Milan, Italy
关键词
POLYUNSATURATED FATTY-ACIDS; GLYCOGEN-STORAGE-DISEASE; FISH-OIL SUPPLEMENTATION; TOTAL ANTIOXIDANT STATUS; PLANNING VEGAN DIETS; BONE-MINERAL DENSITY; OXIDATIVE STRESS; PROTEIN SUBSTITUTE; INBORN-ERRORS; CHILDREN;
D O I
10.1007/s10545-010-9043-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 53 条
  • [1] Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia
    Agostoni, C
    Massetto, N
    Biasucci, G
    Rottoli, A
    Bonvissuto, M
    Bruzzese, AG
    Giovannini, M
    Riva, E
    [J]. JOURNAL OF PEDIATRICS, 2000, 137 (04) : 504 - 509
  • [2] A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria
    Agostoni, C
    Harvie, A
    McCulloch, DL
    Demellweek, C
    Cockburn, F
    Giovannini, M
    Harkness, RA
    Riva, E
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (03) : 207 - 212
  • [3] Breastfeeding rates among hyperphenylalaninemic infants
    Agostoni, C
    Verduci, E
    Fiori, L
    Riva, E
    Giovannini, M
    [J]. ACTA PAEDIATRICA, 2000, 89 (03) : 366 - 367
  • [4] Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children
    Agostoni, C
    Verduci, E
    Massetto, N
    Fiori, L
    Radaelli, G
    Riva, E
    Giovannini, M
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (07) : 582 - 583
  • [5] Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuria
    Agostoni, C
    Verduci, E
    Massetto, N
    Radaelli, G
    Riva, E
    Giovannini, M
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2003, 45 (04) : 257 - 261
  • [6] Complementary feeding: A commentary by the ESPGHAN committee on nutrition
    Agostoni, Carlo
    Decsi, Tamas
    Fewtrell, Mary
    Goulet, Olivier
    Kolacek, Sanja
    Koletzko, Berthold
    Michaelsen, Kim Fleischer
    Moreno, Luis
    Puntis, John
    Rigo, Jacques
    Shamir, Raanan
    Szajewska, Hania
    Turck, Dominique
    van Gdoever, Johannes
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 46 (01) : 99 - 110
  • [7] Al-Qadreh A, 1998, ACTA PAEDIATR, V87, P1162
  • [8] Ambroszkiewicz Jadwiga, 2008, Pol Merkur Lekarski, V25, P57
  • [9] Anderson JW, 1999, AM J CLIN NUTR, V70, P525
  • [10] A longitudinal study of antioxidant status in phenylketonuric patients
    Artuch, R
    Colomé, C
    Sierra, C
    Brandi, N
    Lambruschini, N
    Campistol, J
    Ugarte, D
    Vilaseca, MA
    [J]. CLINICAL BIOCHEMISTRY, 2004, 37 (03) : 198 - 203